Special issue on safety assessment
Regulatory aspects of oncology drug safety evaluation: Past practice, current issues, and the challenge of new drugs
Drug interactions evaluation: An integrated part of risk assessment of therapeutics
The continuing evolution of torsades de pointes liability testing methods: Is there an end in sight?
Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity
Impact of biomarker development on drug safety assessment
Risk assessment of carcinogens in food
The limits of regulatory toxicology
Assessment of herbal medicinal products: Challenges, and opportunities to increase the knowledge base for safety assessment
Polybrominated diphenyl ether levels in foodstuffs collected from three locations from the United States
Dermatotoxicology: Historical perspective and advances
Safety assessment of personal care products/cosmetics and their ingredients
Human health safety evaluation of cosmetics in the EU: A legally imposed challenge to science